Overview

GLP-1 Signaling in Truncally Vagotomized Subjects

Status:
Unknown status

Trial end date:
2018-10-01

Target enrollment:

Participant gender:

Summary

Investigation of the importance of vagal signaling for the glucohomeostatic effects of GLP-1. The study will include physiological studies of truncally vagotomized participants and matched controls.

Phase:

N/A

Details

Lead Sponsor:

University of Copenhagen

Collaborator:

Rigshospitalet, Denmark

Treatments:

Glucagon-Like Peptide 1
Sitagliptin Phosphate